Effect of vNOTES hysterectomy with uterosacral ligament suspension on overactive bladder symptoms in patients with pelvic organ prolapse: a retrospective cohort study
Turkish Journal of Medical Sciences · 13.08.2026 · 56 (4) · 1168-1175
DOI: 10.55730/1300-0144.6361 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 13.08.2026. Verfasst von Gonca Türker Ergün und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Ankara Bilkent City Hospital, Ankara, Turkiye. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive, Pelvic Organ Prolapse, Ligaments, Hysterectomy, Vaginal. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: To evaluate the anatomical and functional outcomes following vaginal natural orifice transluminal endoscopic surgery (vNOTES) hysterectomy combined with bilateral uterosacral ligament suspension in patients with apical prolapse and concomitant overactive bladder symptoms. Materials and methods: This retrospective cohort study was conducted at a single tertiary referral center. Women with symptomatic apical prolapse (stage ≥ II) and concomitant overactive bladder symptoms were included. All patients underwent vNOTES hysterectomy with bilateral uterosacral ligament suspension. Anatomical outcomes were assessed using the Pelvic Organ Prolapse Quantification (POP-Q) system, whereas functional outcomes were evaluated using validated questionnaires, including the Pelvic Floor Distress Inventory-20 (PFDI-20), Overactive Bladder Questionnaire-V8 (OAB-V8), and Overactive Bladder Symptom Score (OABSS).
Results
A total of 25 patients were included in the study. Significant improvements were observed across all POP-Q system parameters at the 3-month postoperative follow-up. Furthermore, assessments of pelvic organ prolapse and overactive bladder symptoms using the PFDI-20, OAB-V8, and OABSS revealed statistically significant postoperative improvements compared with baseline. Overall, among all POP-Q measurements, only the change in point C was significantly associated with improvements in overactive bladder symptom scores measured by the OAB-V8 and OABSS (r = 0.642, p = 0.001; r = 0.589, p = 0.002, respectively).
Conclusion
The vNOTES approach to bilateral uterosacral ligament suspension appears to be an effective minimally invasive technique that not only restores apical anatomical support but also substantially alleviates overactive bladder symptoms. Improvement in apical support may be a key determinant of functional recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Ankara Bilkent City Hospital, Ankara, Turkiye.
ORCID-Profile: Gonca Türker Ergün, Mahmut Kuntay Kokanali, Duygu Tuğrul Ersak, Melike Doğanay, Özlem Moraloğlu Tekin
Zitieren
APA
Türker Ergün, G., Kuntay Kokanali, M., Tuğrul Ersak, D., Doğanay, M., & Moraloğlu Tekin, Ö. (2026). Effect of vNOTES hysterectomy with uterosacral ligament suspension on overactive bladder symptoms in patients with pelvic organ prolapse: a retrospective cohort study . Turkish Journal of Medical Sciences, 56(4), 1168-1175. https://doi.org/10.55730/1300-0144.6361
Vancouver
Türker Ergün G, Kuntay Kokanali M, Tuğrul Ersak D, Doğanay M, Moraloğlu Tekin Ö. Effect of vNOTES hysterectomy with uterosacral ligament suspension on overactive bladder symptoms in patients with pelvic organ prolapse: a retrospective cohort study . Turkish Journal of Medical Sciences. 2026;56(4):1168-1175. doi:10.55730/1300-0144.6361
BibTeX
@article{TrkerErgn2026,
author = {Türker Ergün, Gonca and Kuntay Kokanali, Mahmut and Tuğrul Ersak, Duygu and Doğanay, Melike and Moraloğlu Tekin, Özlem},
title = {Effect of vNOTES hysterectomy with uterosacral ligament suspension on overactive bladder symptoms in patients with pelvic organ prolapse: a retrospective cohort study },
journal = {Turkish Journal of Medical Sciences},
year = {2026},
volume = {56},
number = {4},
pages = {1168--1175},
doi = {10.55730/1300-0144.6361}
}
EUVIMED